Then there’s the possibility there could be less side effects getting a third AZ jab rather than mixing it up getting Pfizer having had AZ for the first two.Some interesting results emerging from Israel, will be interesting to see data from AZ. Would be a real twist in the tale if AZ ends up offering longer efficacy
We can readily make AZ here in Australia and if we could use it for boosters for those who have already had AZ it would help with that rollout.
Last edited: